6-32067917-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001365276.2(TNXB):​c.6288G>A​(p.Pro2096Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0979 in 1,612,468 control chromosomes in the GnomAD database, including 9,958 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.063 ( 465 hom., cov: 32)
Exomes 𝑓: 0.10 ( 9493 hom. )

Consequence

TNXB
NM_001365276.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -5.93

Publications

16 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 6-32067917-C-T is Benign according to our data. Variant chr6-32067917-C-T is described in ClinVar as Benign. ClinVar VariationId is 261146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.93 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNXBNM_001365276.2 linkc.6288G>A p.Pro2096Pro synonymous_variant Exon 18 of 44 ENST00000644971.2 NP_001352205.1
TNXBNM_001428335.1 linkc.7029G>A p.Pro2343Pro synonymous_variant Exon 19 of 45 NP_001415264.1
TNXBNM_019105.8 linkc.6288G>A p.Pro2096Pro synonymous_variant Exon 18 of 44 NP_061978.6 P22105-1O95680Q9Y464O95681

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNXBENST00000644971.2 linkc.6288G>A p.Pro2096Pro synonymous_variant Exon 18 of 44 NM_001365276.2 ENSP00000496448.1 P22105-3
TNXBENST00000647633.1 linkc.7029G>A p.Pro2343Pro synonymous_variant Exon 19 of 45 ENSP00000497649.1 A0A3B3ISX9
TNXBENST00000375244.7 linkc.6288G>A p.Pro2096Pro synonymous_variant Exon 18 of 44 5 ENSP00000364393.3 P22105-3

Frequencies

GnomAD3 genomes
AF:
0.0628
AC:
9544
AN:
152040
Hom.:
465
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0155
Gnomad AMI
AF:
0.0713
Gnomad AMR
AF:
0.0306
Gnomad ASJ
AF:
0.0484
Gnomad EAS
AF:
0.000965
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.0797
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.107
Gnomad OTH
AF:
0.0474
GnomAD2 exomes
AF:
0.0602
AC:
14790
AN:
245642
AF XY:
0.0592
show subpopulations
Gnomad AFR exome
AF:
0.0143
Gnomad AMR exome
AF:
0.0223
Gnomad ASJ exome
AF:
0.0448
Gnomad EAS exome
AF:
0.00162
Gnomad FIN exome
AF:
0.0784
Gnomad NFE exome
AF:
0.102
Gnomad OTH exome
AF:
0.0623
GnomAD4 exome
AF:
0.102
AC:
148267
AN:
1460310
Hom.:
9493
Cov.:
34
AF XY:
0.0982
AC XY:
71369
AN XY:
726444
show subpopulations
African (AFR)
AF:
0.0146
AC:
490
AN:
33474
American (AMR)
AF:
0.0230
AC:
1028
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0487
AC:
1274
AN:
26136
East Asian (EAS)
AF:
0.000907
AC:
36
AN:
39700
South Asian (SAS)
AF:
0.000719
AC:
62
AN:
86224
European-Finnish (FIN)
AF:
0.0811
AC:
4262
AN:
52548
Middle Eastern (MID)
AF:
0.0131
AC:
70
AN:
5340
European-Non Finnish (NFE)
AF:
0.122
AC:
135768
AN:
1111842
Other (OTH)
AF:
0.0875
AC:
5277
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
9924
19848
29771
39695
49619
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4928
9856
14784
19712
24640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0627
AC:
9541
AN:
152158
Hom.:
465
Cov.:
32
AF XY:
0.0583
AC XY:
4339
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.0155
AC:
642
AN:
41510
American (AMR)
AF:
0.0305
AC:
466
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0484
AC:
168
AN:
3470
East Asian (EAS)
AF:
0.000967
AC:
5
AN:
5170
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4816
European-Finnish (FIN)
AF:
0.0797
AC:
845
AN:
10608
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.107
AC:
7242
AN:
67972
Other (OTH)
AF:
0.0469
AC:
99
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
438
875
1313
1750
2188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0741
Hom.:
263
Bravo
AF:
0.0575
EpiCase
AF:
0.0957
EpiControl
AF:
0.0874

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Dec 24, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
0.76
DANN
Benign
0.65
PhyloP100
-5.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1150756; hg19: chr6-32035694; COSMIC: COSV64479042; API